Bionexus Gene Lab Corp has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on July 20, 2023 with the ratio of 1-for-12, meaning that for 12 shares of BGLC owned pre-split, shareholders then owned 1 share. The most recent stock split took place on April 07, 2025 on a 1-for-10 basis.
These actions have increased BGLC stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Bionexus Gene Lab Corp's total market capitalization.
For more detailed information of Bionexus Gene Lab Corp's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Bionexus Gene Lab Corp has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when BGLC stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Bionexus Gene Lab Corp's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
